Article
Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway.
Journal of neuroimmunology - 1 Jun 1990
Carr D J, DeCosta B R, Jacobson A E, Rice K C, Blalock J E
Abstract excerpt
Overnight treatment of murine leukocytes with corticotropin-releasing hormone (CRH) and arginine vasopressin enhances natural killer cell activity. Moreover, the opioid receptor antagonist, naloxone, as well as the delta-class opioid receptor antagonist, naltrindole, can block this effect. The re...
Topics
- Animals
- Corticotropin-Releasing Hormone
- Female
- In Vitro Techniques
- Killer Cells, Natural
- Kinetics
- Macrophages
- Mice
- Mice, Inbred BALB C
- Naloxone
- Phenotype
- Receptors, Opioid
- Spleen
- beta-Endorphin
